Parkinson`s Disease Clinical Trial
Official title:
Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson`s Disease
The purpose of the study is to evaluate whether Viusid/Alzer Nutritional supplements, could improve the progression disease, in patients with Parkinson's Disease (PD).
Periodical measures of the clinical features with UPDRS will be done at the beginning, each three months until two years. Each group will be compare to evaluate. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02224664 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson`s Disease
|
Phase 1 | |
| Recruiting |
NCT01338662 -
Comparison of the Incidence of Dyskinesia in Parkinson`s Disease Who Were Treated With Amantadine or Dopamine Agonist
|
N/A | |
| Unknown status |
NCT01313819 -
The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy
|
Phase 4 |